Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy

Objective. To determine whether transcutaneous bilirubin measurements (TcB) before and during phototherapy taken from covered skin during phototherapy correlate with total serum bilirubin (TSB) levels. Study Design. In this prospective observational study, healthy term newborns who required TSB meas...

Full description

Saved in:
Bibliographic Details
Main Author: Saad Abdullah Alsaedi
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:International Journal of Pediatrics
Online Access:http://dx.doi.org/10.1155/2018/4856390
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832563440632201216
author Saad Abdullah Alsaedi
author_facet Saad Abdullah Alsaedi
author_sort Saad Abdullah Alsaedi
collection DOAJ
description Objective. To determine whether transcutaneous bilirubin measurements (TcB) before and during phototherapy taken from covered skin during phototherapy correlate with total serum bilirubin (TSB) levels. Study Design. In this prospective observational study, healthy term newborns who required TSB measurements were included. TcB measurements were taken from the forehead before starting and during phototherapy using the BiliChek device. Before starting phototherapy, part of the forehead was covered. Blood for TSB measurement was collected within 5 minutes of TcB measurements. Correlations and mean differences between TcB and TSB before and during phototherapy were calculated. Result. Paired TSB and TcB measurements before and during phototherapy in 151 newborns were performed. The mean gestational age was 38.8 weeks and birth weight was 3.1 kg; 53% were male. Before starting phototherapy, TSB and TcB were 183.8±41.6 and 190.5 ± 43 μmol/l, respectively. During phototherapy, TSB and TcB were 191.8±39.4 and 187.8±45.3 μmol/l, respectively. Linear regression analysis showed a significant correlation between TcB and TSB before starting phototherapy and during phototherapy (r: 0.85; p<0.001 and r: 80.0; p<0.001), respectively. Before starting phototherapy, the mean difference between TSB and TcB was 6.2±23.2 μmol/l, with a 95% CI of −39.3 to 51.7 μmol. During phototherapy, the mean difference was −2.8±23.5 μmol/l, with a 95% CI of −48.9 to 43.3 μmol/l. Conclusion. TcB measurements from covered skin in jaundiced term infants during phototherapy correlate with TSB and can be used to monitor bilirubin levels during phototherapy.
format Article
id doaj-art-825a72d3d21a440fa9e4ce11f80565e9
institution Kabale University
issn 1687-9740
1687-9759
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series International Journal of Pediatrics
spelling doaj-art-825a72d3d21a440fa9e4ce11f80565e92025-02-03T01:20:17ZengWileyInternational Journal of Pediatrics1687-97401687-97592018-01-01201810.1155/2018/48563904856390Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during PhototherapySaad Abdullah Alsaedi0Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi ArabiaObjective. To determine whether transcutaneous bilirubin measurements (TcB) before and during phototherapy taken from covered skin during phototherapy correlate with total serum bilirubin (TSB) levels. Study Design. In this prospective observational study, healthy term newborns who required TSB measurements were included. TcB measurements were taken from the forehead before starting and during phototherapy using the BiliChek device. Before starting phototherapy, part of the forehead was covered. Blood for TSB measurement was collected within 5 minutes of TcB measurements. Correlations and mean differences between TcB and TSB before and during phototherapy were calculated. Result. Paired TSB and TcB measurements before and during phototherapy in 151 newborns were performed. The mean gestational age was 38.8 weeks and birth weight was 3.1 kg; 53% were male. Before starting phototherapy, TSB and TcB were 183.8±41.6 and 190.5 ± 43 μmol/l, respectively. During phototherapy, TSB and TcB were 191.8±39.4 and 187.8±45.3 μmol/l, respectively. Linear regression analysis showed a significant correlation between TcB and TSB before starting phototherapy and during phototherapy (r: 0.85; p<0.001 and r: 80.0; p<0.001), respectively. Before starting phototherapy, the mean difference between TSB and TcB was 6.2±23.2 μmol/l, with a 95% CI of −39.3 to 51.7 μmol. During phototherapy, the mean difference was −2.8±23.5 μmol/l, with a 95% CI of −48.9 to 43.3 μmol/l. Conclusion. TcB measurements from covered skin in jaundiced term infants during phototherapy correlate with TSB and can be used to monitor bilirubin levels during phototherapy.http://dx.doi.org/10.1155/2018/4856390
spellingShingle Saad Abdullah Alsaedi
Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
International Journal of Pediatrics
title Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
title_full Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
title_fullStr Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
title_full_unstemmed Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
title_short Transcutaneous Bilirubin Measurements Can Be Used to Measure Bilirubin Levels during Phototherapy
title_sort transcutaneous bilirubin measurements can be used to measure bilirubin levels during phototherapy
url http://dx.doi.org/10.1155/2018/4856390
work_keys_str_mv AT saadabdullahalsaedi transcutaneousbilirubinmeasurementscanbeusedtomeasurebilirubinlevelsduringphototherapy